Ireland
# |
Name |
Price to Earnings Ratio (P/E) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
47.12 |
Jan. 14, 2025 | USD 207.57 | 0.10% |
|
Ireland |
|
2 |
32.19 |
Jan. 14, 2025 | USD 42.18 | 0.76% |
|
Ireland |
|
3 |
25.49 |
Jan. 14, 2025 | USD 85.25 | 4.23% |
|
Ireland |
|
4 |
19.44 |
Jan. 14, 2025 | USD 93.99 | 0.60% |
|
Ireland |
|
5 |
11.32 |
Jan. 14, 2025 | USD 2.05 | 2.67% |
|
Ireland |
|
6 |
-0.32 |
Jan. 14, 2025 | USD 0.02 | -6.17% |
|
Ireland |
|
7 |
-187.01 |
Jan. 13, 2025 | USD 69.11 | -2.10% |
|
Ireland |
The Pharmaceuticals company in Ireland with the highest Price to Earnings Ratio (P/E) is STERIS plc (NYSE: STE) at 47.12.
The Pharmaceuticals company in Ireland with the lowest Price to Earnings Ratio (P/E) is Cosmo Pharmaceuticals N.V. (LSE: 0RGI.L) at -187.01.
The top 10 Pharmaceuticals companies in Ireland by Price to Earnings Ratio (P/E) are STERIS plc, Experian plc, Medtronic plc, Kerry Group plc, Uniphar plc, Ovoca Bio plc and Cosmo Pharmaceuticals N.V..
The bottom 10 Pharmaceuticals companies in Ireland by Price to Earnings Ratio (P/E) are Cosmo Pharmaceuticals N.V., Ovoca Bio plc, Uniphar plc, Kerry Group plc, Medtronic plc, Experian plc and STERIS plc.